References
- 1. WHO. World Malaria Report, 2005. Geneva: World Health Organization/United Nations Children’s Fund. 2005.
- 2. Langhorne J, Ndungu FM, Sponaas AM, Marsh K. Immunity to malaria: more questions than answers. Nat Immunol. 2008; 9:725-32.10.1038/ni.f.205
- 3. WHO. Malaria Control and Elimination Programme. 2008. [Cited 2011 Aug 09]. Available from http://www.emro.who.int/rbm/CountryProfiles-pak.htm.
- 4. Kwiatkowski DP. How Malaria Has Affected the Human Genome and What Human Genetics Can Teach Us about Malaria. Am J Hum Genet. 2005; 77:171-92.10.1086/432519
- 5. Ouma C, Davenport GC, Were T, Otieno MF, Hittner JB, Vulule JM, et al. Haplotypes of IL-10 promoter variants are associated with susceptibility to severe malarial anemia and functional changes in IL-10 production. Hum Genet. 2008; 124:515-24.10.1007/s00439-008-0578-5
- 6. Cyktor JC and Turner J. IL-10 and immunity against prokaryotic and eukaryotic intracellular pathogens. Infect. Immun. 2011. doi: 10.1128/IAI.00047-11.
- 7. Afzal MS, Tahir S, Salman A, Baig TA, Shafi T, Zaidi NS, et al. Analysis of interleukin-10 gene polymorphisms and hepatitis C susceptibility in Pakistan. J Infect Dev Ctries. 2011; 5:473-9.
- 8. Koss K, Satsangi J, Fanning GC, Welsh KI, Jewell DP. Cytokine (TNF alpha, LT alpha and IL-10) polymorphisms in inflammatory bowel diseases and normal controls: differential effects on production and allele frequencies. Genes Immun. 2000; 1:185-90.10.1038/sj.gene.6363657
- 9. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphism in the interleukin-10 gene promoter. Eur. J. Immunogenet. 1997; 24:1-8.10.1111/j.1365-2370.1997.tb00001.x
- 10. Settin A, Hassan H, El-Baz R, Hassan T. Association of cytokine gene polymorphisms with psoriasis in cases from the Nile Delta of Egypt. Acta Dermatovenerol Alp Panonica Adriat. 2009; 18:105-12.
- 11. Lopez P, Gutierrez C, Suarez A. IL-10 and TNF alpha genotypes in SLE. J Biomed Biotechnol. 2010; doi: 10.1155/2010/838390.
- 12. Resende RG, Correia-Silva JF, Arao TC, Silva TA, Abreu MH, Bittencourt H, et al. Investigation of functional IL-10 gene polymorphism and IL-10 levels in acute graft-versus-host disease. Journal of Clinical Immunology. 2010; 30:465-73.10.1007/s10875-010-9377-6
- 13. Lee YH, Bae SC, Choi SJ, Ji JD, Song GG. Associations between interleukin-10 polymorphisms and susceptibility to rheumatoid arthritis: a meta-analysis. Mol Biol Rep. 2011; DOI: 10.1007/s11033-011-0712-7.10.1007/s11033-011-0712-7
- 14. Perrey C, Turner ST, Pravica V, Howell WM, Hutchinson IV. ARMS-PCR methodologies to determine IL- 10, TNF.α, TNF-β and TGF-β1 gene polymorphisms. Transplant Immunology. 1998; 7:127-8.
- 15. Mok CC, Lanchbury JS, Chan DW, LAU CS. Interleukin-10 promoter polymorphisms in Southern Chinese patients with systemic lupus erythematosus. Arthritis Rheum. 1998; 41:1090-95.10.1002/1529-0131(199806)41:6<;1090::AID-ART16>3.0.CO;2-6
- 16. Eid NA, Hussein AA, Zein A, Mohamed HS, Rockett KA, Kwiatkowski DP, et al. Research Candidate malaria susceptibility/protective SNPs in hospital and population-based studies: the effect of substructuring. Malaria Journal. 2010; 9:119. doi:10.1186/1475-2875-9-119.
- 17. Ollier WE. Cytokine genes and disease susceptibility. Cytokine. 2004; 28:174-8.15588692
- 18. Hohler T, Reuss E, Freitag CM, Schneider PM. A functional polymorphism in the IL-10 promoter influences the response after vaccination with HBsAg and hepatitis A. Hepatology. 2005; 42:72-6.10.1002/hep.20740
- 19. Wilson JN, Rockett K, Jallow M, Pinder M, Sisay-Joof F, Newport M, et al. Analysis of IL-10 haplotypic associations with severe malaria. Genes and Immunity. 2005; 6:462-6.10.1038/sj.gene.6364227
- 20. Ohashi J, Naka I, Patarapotikul J, Hananantachai H, Looareesuwan S, Tokunaga K . Lack of association between interleukin-10 gene promoter polymorphism, -1082G/A, and severe malaria in Thailand. Southeast Asian J Trop Med Public Health. 2002; 3:5-7.
- 21. Vafa M, Maiga B, Berzins K, Hayano M, Bereczky S, Dolo A, et al. Associations between the IL-4 -590 T allele and Plasmodium falciparum infection prevalence in asymptomatic Fulani of Mali. Microbes and Infection. 2007; 9:1043-8.
- 22. Linke A, Kühn R, Müller W, Honarvar N, Li C, Langhorne J. Plasmodium chabaudi chabaudi: differential susceptibility of gene-targeted mice deficient in IL-10 to an erythrocytic-stage infection. Exp Parasitol. 1996; 84:253-63.10.1006/expr.1996.0111
- 23. Carpenter D, Rooth I, Farnert A, Abushama H, Quinnell RJ, Shaw M. Genetics of susceptibility to malaria related phenotypes. Infection, Genetics and Evolution. 2009; 9:97-103.10.1016/j.meegid.2008.10.008
- 24. Sanni LA, Jarra W, Li C, Langhorne J. Cerebral malaria and cerebral hemorrhages in interleukin-10-deficient mice infected with Plasmodium chabaudi. Infect Immun. 2004; 72:3054-8.10.1128/IAI.72.5.3054-3058.2004
- 25. Wilson ON, Bythwood T, Solomon W, Jolly P, Yatich N, Jiang Y, et al. Elevated Levels of IL-10 and G-CSF Associated with Asymptomatic Malaria in Pregnant Women. Infectious Diseases in Obstetrics and Gynecology. 2010; Article ID 317430, doi:10.1155/2010/317430
- 26. Kurtzhals JA, Adabayeri V, Goka BQ, Akanmori BD, Oliver- Commey JO, Nkrumah FK. Low plasma concentrations of interleukin 10 in severe malarial anaemia compared with cerebral and uncomplicated malaria. Lancet. 1998; 351:1768-2.10.1016/S0140-6736(97)09439-7
- 27. Yao JG, Gao LB, Liu YG, Li J, Pang GF. Genetic variation in interleukin-10 gene and risk of oral cancer. Clin Chim Acta. 2008; 388:84-8.10.1016/j.cca.2007.10.012